Roche Molecular Systems, Inc. v. Foresight Diagnostics Inc.

Summary

The United States District Court for the Northern District of California ruled on Stanford’s motion to dismiss Roche’s first amended complaint alleging trade secret misappropriation and related claims. The court dismissed the DTSA and CUTSA claims against Stanford without prejudice and granted leave to amend, while denying dismissal of Roche’s declaratory judgment claim concerning ownership of disputed patent applications. The court also noted that Count 8, alleging unfair competition, would be withdrawn by agreement.

Holdings

1. Roche failed to state plausible DTSA and CUTSA misappropriation claims against Stanford because its allegations that Stanford knew or had reason to know that the disputed technology involved Roche trade secrets were general and conclusory.
2. Roche plausibly stated a declaratory-judgment claim because it alleged an actual controversy with Stanford and Foresight regarding ownership of the disputed patent applications.
3. The court could not consider Stanford's policies on the motion to dismiss because the amended complaint did not refer extensively to them or make them the basis of Roche's claims.

Questions Presented

1. Whether Roche plausibly alleged that Stanford knowingly misappropriated Roche's trade secrets under the Defend Trade Secrets Act and the California Uniform Trade Secrets Act.
2. Whether Roche's allegations stated a justiciable declaratory-judgment claim concerning ownership of the disputed patent applications.
3. Whether the court could consider Stanford's policies and related documents on a motion to dismiss through incorporation by reference.

Disposition

other